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Macrophages infiltrate adipose tissue in obesity
and are involved in the induction of inflammation,
thereby contributing to the development of obesity-
associated metabolic disorders. Here, we show
that the macrophage-derived soluble protein AIM is
endocytosed into adipocytes via CD36. Within adi-
pocytes, AIM associates with cytosolic fatty acid
synthase (FAS), thereby decreasing FAS activity.
This decreases lipid droplet size, stimulating the
efflux of free fatty acids and glycerol from adipo-
cytes. As an additional consequence of FAS inhibi-
tion, AIM prevents preadipocyte maturation. In vivo,
the increase in adipocyte size and fat weight induced
by high-fat diet (HFD) was accelerated in AIM-defi-
cient (AIM/) mice compared to AIM+/+ mice. More-
over, injection of recombinant AIM in AIM/ mice
suppresses the increase in fat mass induced by
HFD. Interestingly, metabolic rates are comparable
in AIM/ and AIM+/+ mice, suggesting that AIM
specifically influences adipocyte status. Thus, this
AIM function in adipocytes may be physiologically
relevant to obesity progression.
INTRODUCTION
It is well known that adipose tissues in obesity are in a state of
chronic inflammation (Olshansky et al., 2005; Baker et al.,
2007). Accumulating evidence indicates that this inflammation
is induced predominantly by the recruitment of a large number
of macrophages into adipose tissues (Olshansky et al., 2005;
Baker et al., 2007; Apovian et al., 2008). Although the precise
mechanism underlying the initiation of macrophage recruitmentCto adipose tissues remains a matter of debate, adipose tissue
macrophage number rapidly increases as obesity progresses
(Surmi and Hasty, 2008). The subclinical inflammatory state of
adipose tissues is tightly associated with insulin resistance of
adipose tissues as well as systemic insulin resistance and
cardiovascular disease (Neels and Olefsky, 2006; Shoelson
et al., 2006). Thus, adipose tissue macrophages are thought to
play key roles in several obesity-induced metabolic disorders.
However, whether adipose tissuemacrophages also exert direct
effect(s) on surrounding adipocytes, independent of inflamma-
tory responses, remains to be determined. To address this ques-
tion, we focused on the protein AIM (apoptosis inhibitor of
macrophage, also known Spa, Api6, and CD5L) in the context
of its effects on adipocytes, because AIM is produced and
secreted specifically by tissue macrophages, and its expression
in vivo is markedly increased with obesity progression in mice
(Miyazaki et al., 1999; Arai et al., 2005).
The AIM protein is a member of the scavenger receptor
cysteine-rich superfamily (SRCR-SF) and was initially identified
as an apoptosis inhibitor that supports the survival of macro-
phages themselves against various apoptosis-inducing stimuli
(Miyazaki et al., 1999). As a secreted molecule, AIM has been
detected in human and mouse blood at varying levels (Miyazaki
et al., 1999; Gebe et al., 1997, 2000; Gangadharan et al., 2007;
Kim et al., 2008; Gray et al., 2009). Based on the observation
that AIM is a direct target for regulation by nuclear receptor
LXR/RXR heterodimers (Joseph et al., 2004; Valledor et al.,
2004), we found that AIM is expressed in lipid-laden macro-
phages at atherosclerotic lesions, and this induction is associ-
ated with atherosclerogenesis by supporting the survival of
macrophages within lesions (Arai et al., 2005). Other studies
have shown that AIM appears to be multifunctional and is effec-
tive in cell types other than macrophages, including B and
natural killer (NK) T lymphocytes (Yusa et al., 1999; Kuwata
et al., 2003) and myeloid cells (Qu et al., 2009). However, the
functional nature of AIM remains enigmatic becausewe are igno-
rant of the precise mechanism by which it elicits its effects.ell Metabolism 11, 479–492, June 9, 2010 ª2010 Elsevier Inc. 479
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Role of AIM in AdiposityIn the present study, we assessed the expression of AIM by
adipose tissue macrophages in obese mice. We also analyzed
how AIM interacts with adipocytes. In addition, an effect of
AIM on adipocytes and its consequence with respect to the
regulation of adipocyte size in vivo was determined. Finally, we
investigated the molecular mechanism underlying this role of
AIM in adipocytes. Based on these results, we will discuss the
putative role of AIM on the state of adipose tissues.
RESULTS
AIM in Adipose Tissue Macrophages in Obese Mice
We first assessed the expression of AIM by adipose tissue
macrophages in obese C57BL/6 (B6) mice after the administra-
tion of a high-fat diet (HFD) (fat kcal 60%) for 20 weeks. In obese
mice, large numbers of macrophages were observed within
visceral fat tissues, forming clusters or crown-like structures
(CLSs) (Cinti et al., 2005), whereas few adipose tissue macro-
phages were detected in lean mice (Figure 1A). As shown in
Figure 1B, macrophages (stained with F4/80 pan macrophage
antibody) in obese adipose tissues showed staining with an anti-
body specific to AIM (SA-1) (Arai et al., 2005). These AIM-positive
macrophages were also positive for interleukin (IL)-6 staining,
indicating that they were the inflammatory macrophage type
(M1) (Figure 1B). In contrast, F4/80-positive macrophages within
adipose tissues from lean mice were negative for AIM and IL-6
staining (Figure 1B). Similarly, the serum level of AIM was
increased in obese mice compared to lean mice (Figure 1C). It
is possible that AIM detectable in lean mice is derived predomi-
nantly from macrophages in other macrophage-containing tis-
sues (Miyazaki et al., 1999; Gebe et al., 2000; Arai et al., 2005).
To exclude the possible expression of AIM by adipocytes, adipo-
cytes from epididymal fat tissue of obese mice were fractionated
after collagenase treatment (Brake et al., 2006) and assessed
for AIM expression by quantitative real-time PCR (QPCR). No
AIM expression was observed in purified adipocytes (Fig-
ure S1A). In addition, 3T3-L1 adipocytes were analyzed after
the induction of maturation by insulin, dexamethasone (DEX),
and isobutylmethylxanthine (IBMX). Again, AIM expression was
not detectable in mature 3T3-L1 adipocytes (Figure S1B).
Endocytosis of AIM into Adipocytes
Intriguingly, althoughwe found noAIM expression by adipocytes
(Figure S1), some adipocytes surrounding adipose tissuemacro-
phages in obese mice showed AIM staining (Figure 2A, arrows).
This may indicate a physiologic association of AIM with tissue
adipocytes. To test this possibility, we injected recombinant
AIM (rAIM) into epididymal fat in obese male AIM/ mice and
analyzed fat tissue histologically 3 hr later. Epididymal fat was
selected for this experiment owing to its ease of manipulation.
Interaction of AIM with adipocytes was clearly confirmed in
AIM/ mice. As shown in Figure 2B (left and middle lanes),
AIM/ adipocytes were positive for AIM staining when rAIM
was injected locally into fat tissue (Figure 2B, left and middle
lanes). Staining for AIM was also detected in adipocytes in fat
tissue in which rAIM was administered systemically to AIM/
mice via intravenous (i.v.) injection (Figure 2B, right lane). These
results implicate adipocytes as a target cell type for AIM. Macro-
phages also stained for AIM in AIM/ adipose tissue after injec-480 Cell Metabolism 11, 479–492, June 9, 2010 ª2010 Elsevier Inc.tion of rAIM (Figure 2B), consistent with the fact that AIM is effec-
tive in macrophages (Miyazaki et al., 1999; Arai et al., 2005).
To further investigate how AIM interacts with adipocytes,
differentiated 3T3-L1 adipocytes were treated with rAIM, and
the association of rAIMwith these cells was analyzed by confocal
microscopy. Interestingly, rAIM accumulated within the cyto-
plasm of adipocytes, forming many dots within the intracellular
compartment (Figure 3A). After stimulation with insulin, DEX,
and IBMX, a large proportion of 3T3-L1 cells underwent differen-
tiation, expressing peroxisome proliferator-activated receptor g
2 (PPARg2) at a high level, whereas some cells remained in an
undifferentiated state, expressing PPARg2 at a low or undetect-
able level (Madsen et al., 2003). As shown in Figure 3A, among
this heterogeneous cell population, mature adipocytes strongly
positive for PPARg2 (yellow arrows) efficiently incorporated
rAIM, whereas adipocytes faintly positive for PPARg2 (blue
arrows) or negative (white arrows) did not (left and middle lanes).
Preadipocytes not stimulated by insulin, DEX, and IBMX did not
incorporate rAIM (Figure 3A, right lane). As shown in Figure 3B,
incorporated rAIM colocalized with early endosomes (positive
for early endosome antigen 1; EEA1) but notwith late endosomes
(positive for Rab7) or recycling endosomes (positive for Rab11).
These results suggest that incorporated AIM was transported
to the cytosol during endosome maturation. No costaining for
AIM and lysosomes or lipid droplets was observed (Figure 3B;
AIM + lysosome, AIM + lipid droplets). Additional analysis of
the cells by electronmicroscopy shownmay support the specific
colocalization of AIM with endosomes (Figures 3C and S2). Gold
particles indicating rAIM immunoreactivity were mainly associ-
ated with endosome-like structures, where the limiting mem-
brane of the structures and the periphery of their contents were
heavily labeled (Figure 3C). Endocytosis of rAIM was observed
at the cell membrane (Figure 3C, indicated by arrows). Other
organelles were essentially negative for AIM immunolabeling
(Figure S2). All these data suggest that AIM is incorporated into
adipocytes via endocytosis, is transported to the cytoplasm,
and function intracellularly.
Cell-Surface CD36-Mediated Internalization of AIM
The accumulation of AIM at the membrane of endosome-like
particles (Figure 3C) indicates that the internalization of exoge-
nous AIM may be mediated by a cell-surface molecule. As
a candidate molecule responsible for endocytosis, we focused
on scavenger receptor CD36 because it promotes the internali-
zation of various molecules, including lipoproteins and fatty
acids (Greenwalt et al., 1992; Ibrahimi and Abumrad, 2002),
and it is expressed by adipocytes and macrophages, which
are target cells for AIM. Thus, we assessed whether treatment
of 3T3-L1 adipocytes with a neutralizing antibody against
CD36 (clone JC63.1; mouse IgA) interfered with rAIM uptake.
As shown in Figure 3D, incorporation of rAIM was drastically
decreased in the presence of this neutralizing antibody. In addi-
tion, we injected rAIM intravenously into CD36/ (Febbraio
et al., 1999) and CD36+/+ mice and analyzed the incorporation
of rAIM into adipose tissues. As shown in Figure 3E, incorpora-
tion of rAIM into adipocytes was markedly less in CD36/
mice compared to CD36+/+ mice. These data strongly indicate
that CD36 is responsible for AIM internalization. This was also
supported by microscopic analysis of the association of rAIM
Figure 1. Immunohistochemical Analysis of AIM in Adipose Tissues
(A) Representative photomicrographs of visceral fat tissue from lean (fed with normal chow) or obese (fed with a HFD for 20 weeks) wild-type B6mice stained with
hematoxylin and eosin (H&E). The crown-like structures (CLSs) formed by recruited macrophages are indicated by arrows.
(B)Specimensof visceral fat tissues from leanorobeseB6micewerecostained forAIM (green)andF4/80 (panmacrophagemarker; red)orAIM (green)and IL-6 (red).
(C) Immunoblotting for serum AIM. A volume of 1 ml of serum from six separate lean (fed with normal chow) or obese (fed with a HFD for 20 weeks) mice was used.
Results for immunoblots and actual AIM concentration are presented. AIM concentration was calculated by comparison with the density obtained with various
amounts of recombinant AIM (rAIM) on the same blot. The density of the signal was calculated using image analysis software NIH ImageJ. Error bar indicates SEM.
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Role of AIM in Adipositywith Flag-tagged mouse CD36 expressed on the surface of
HEK293T cells. Notably, the accumulation of rAIM staining
(green) was specifically colocalized with Flag-CD36 (red) on
the cell surface (Figure S3).CAIM Decreases Adipocyte Lipid Droplet Size
We next assessed the effect of incorporated AIM in host adipo-
cytes. To achieve this, differentiated 3T3-L1 adipocytes in
culture (at 4 days after maturation stimulation) were challengedell Metabolism 11, 479–492, June 9, 2010 ª2010 Elsevier Inc. 481
Figure 2. Association of Exogenous AIM with Adipocytes
(A) Epididymal fat sections were stained for AIM (green) and F4/80 (red). Staining for AIM was detected in macrophages and some adipocytes (arrows).
(B) Uptake of rAIM by AIM/ adipocytes in vivo. AIM/mice were injected with rAIM (middle lane) or BSA (left lane) directly into the epididymal fat (total 100 mg
for each at several loci) or with rAIM systemically (300 mg) via i.v. injection (right lane). Three hours after injection, tissue sections were generated and stained for
AIM (green) and macrophage F4/80 (red). mac: macrophage.
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Role of AIM in Adipositywith rAIM. Remarkably, the size of lipid droplets within the cells
was decreased after a 6 day incubation of cells with rAIM (Fig-
ure 4A). In addition, the number of cells containing lipid droplets
was also decreased (Figure 4A). Supernatant viscosity was also
markedly enhanced by the administration of rAIM. These results
suggest that rAIM induced a lipolytic response, resulting in the
liberation of droplet components such as glycerol and fatty acids
from the cells (Zechner et al., 2005; Duncan et al., 2007). We
tested this possibility by determining the efflux of glycerol and
free fatty acids (FFAs) on days 2, 4, and 6 after stimulation with
rAIM. As shown in Figure 4B, the amount of glycerol and FFAs
in the supernatant increased significantly when adipocytes
were maintained in rAIM. In vivo, basal levels of FFA and glycerol
in serum were lower in AIM/ obese mice than in AIM+/+ obese
mice (Figure 4C), consistent with the in vitro results.
mRNA levels for fat-specific protein 27 (FSP27, also termed
cidec), Perilipin, and Adipophilin, important elements involved
in the formation of lipid droplets (Ducharme and Bickel, 2008;
Puri and Czech, 2008), were decreased after treatment of 3T3-482 Cell Metabolism 11, 479–492, June 9, 2010 ª2010 Elsevier Inc.L1 adipocytes with rAIM (Figure 4D). A significant decrease in
these mRNA levels was already apparent 2 days after challenge
with rAIM (Figure 4D), consistent with the progression of lipol-
ysis, as reported previously (Zechner et al., 2005; Nishino
et al., 2008). In contrast, mRNA level of mature adipocyte
markers such as PPARg2, CCAAT-enhancer-binding protein
a (C/EBPa), and glucose transporter 4 (GLUT4) and an immature
adipocyte marker, Preadipocyte factor-1 (PREF-1) (Smas and
Sul, 1993), was not remarkably changed in response to rAIM
treatment, suggesting that rAIM did not appear to induce dedif-
ferentiation of adipocytes (Figure 4D). Local injection of rAIM into
epididymal fat tissue of AIM/ mice resulted in similar changes
in mRNA levels of these genes (Figure 4E).
Increase in Adipocyte Size and Adipose Tissue Mass
in AIM/ Mice
Consistent with the observations in 3T3-L1 cells, the size of
visceral fat adipocytes was larger in obese AIM/ mice than in
obese AIM+/+ mice (Figure 5A). Relevant to this enlargement of
Cell Metabolism
Role of AIM in Adiposityadipocytes, the increase in weight of both visceral and subcuta-
neous fat tissues in mice fed with a HFD (12 weeks) was more
accelerated in AIM/ mice than in AIM+/+ mice (Figure 5B).
This difference was also apparent in mice fed with a HFD for
a longer period (20 weeks) (Figure S4). It is noteworthy that
AIM/ mice and AIM+/+ mice fed with a HFD showed com-
parable metabolic rates (e.g., body temperature, oxygen con-
sumption, and food intake) (Figure S5). Locomotor activity
was also equivalent in both types of mice (Figure S5). Thus,
AIM appears to influence adipose tissue mass by specifically
affecting adipocytes.
We also injected rAIM intraperitoneally (twice a week) into
AIM/ mice fed with a HFD for 5 weeks to assess whether
rAIM administration might suppress the increase in adipose
tissue mass. As expected, the increase in weight of whole-body
as well as both visceral and subcutaneous fat tissues was signif-
icantly less in mice injected with rAIM than in those injected with
bovine serum albumin (BSA) (Figure 5C). As observed for the
treatment of 3T3-L1 adipocytes with rAIM (Figure 4D), mRNA
levels of FSP27, Perilipin, and Adipophilin were also lower in
the epididymal adipose tissue in mice injected with rAIM (Fig-
ure 5D). Interestingly, mRNA level of PREF-1 was higher in
rAIM-injected mice, although that of PPARg2, C/EBPa, or
GLUT4was similar in mice injected with rAIM or BSA (Figure 5D).
AIM Decreased Fatty Acid Synthase Activity
Wewere interested in the intracellular target molecule(s) of incor-
porated AIM in adipocytes. To this end, we performed immuno-
precipitation-mass spectrometry (IP-MS) analysis with lysates
from different cells and tissues. Fatty acid synthase (FAS) was
identified as a candidate molecule with the potential to associate
with AIM (other proteins, including carbamoyl phosphate syn-
thase-1, major vault protein, and aldehyde dehydrogenase 1
family member L1, were also associated with AIM; complete
results of this analysis will be published elsewhere). FAS is highly
expressed in adipose tissues and catalyzes the synthesis of
saturated fatty acids, such as palmitate, from acetyl-CoA and
malonyl-CoA precursors. Accumulating evidence has high-
lighted critical roles of FAS in a variety of biological aspects,
including early embryogenesis (Chirala et al., 2003), in addition
to providing a metabolic substrate. A number of biochemical
and genetic studies have suggested the involvement of FAS in
the regulation of adipose tissue mass (Loftus et al., 2000; Maki-
mura et al., 2001; Kumar et al., 2002; Mobbs and Makimura,
2002; Shimokawa et al., 2002; Kovacs et al., 2004; Liu et al.,
2004; Ronnett et al., 2005; Schmid et al., 2005; Chakravarthy
et al., 2009a).
We confirmed the association of AIM and FAS in vivo and
in vitro. After injecting rAIM into epididymal fat of obese AIM/
mice, we precipitated incorporated rAIM from fat tissue lysates
and addressed whether endogenous FAS was also precipitated.
As shown in Figure 6A, the proteins coprecipitated, confirming
the association of incorporated AIM and cytosolic FAS. In addi-
tion, a coimmunoprecipitation (coIP) assay with HEK293T cells
expressing Flag-tagged FAS and HA-tagged AIM showed that
the two proteins coprecipitated, indicating that AIM possesses
the potential to bind to FAS (Figure 6B).
We also attempted to map FAS-binding region(s) for AIM. FAS
consists of seven discrete functional domains: ketoacyl syn-Cthase (KS), malonyl/acetyl transferase (MAT), dehydrase (DH),
enoylreductase (ER), ketoreductase (KR), acyl carrier protein
(ACP), and thioesterase (TE) (Smith, 1994). There is a central
core (CC) between the DH and ER domains that has no known
catalytic function and may play a structural role in stabilizing
the dimer (illustrated in schematic in Figure 6C). We assessed
the association of HA-tagged AIM with each FAS region tagged
with a Flag sequence by coIP assay. Notably, AIM bound specif-
ically to ER, DH, TE, and CC domains, but not to the N-terminal
region containing KS and MAT, which are involved in the initial
acyl chain assembly (i.e., condensation of acetyl and malonyl
moieties to 3-ketobutyryl-ACP along with the release of CO2)
(Figures 6C and S6). Thus, AIM appears to influence the elonga-
tion of fatty acid chains (which involves ER and DH) and the
release of synthesized palmitate (which is dependent on TE).
The association of AIM with the CC domain suggested that
AIM might also affect the dimerization of FAS. It is well known
that FAS is highly functional as a dimerized form, whereas
monomeric FAS possesses little or no activity (Smith et al.,
1985; Asturias et al., 2005). Therefore, we analyzed the dimer/
monomer status of FAS protein in 3T3-L1 adipocytes after
culture in the presence or absence of rAIM for 6 days. As
expected, the proportion of dimerized FAS (500 kDa) (as as-
sessed by separation of FAS on a Tris-acetate gel specific for
large molecular weight proteins) was significantly less in cells
maintained in the presence of rAIM than in cells without rAIM
treatment (Figure 6D).
Consistent with these results, the enzymatic activity of FAS (as
assessed by the consumption of malonyl-CoA) (Kelley et al.,
1986) was markedly decreased in 3T3-L1 adipocytes treated
with rAIM as above (Figure 6E). The decrease in FAS activity
induced by rAIM (5 mg/ml) was at a similar level to that induced
by C75, a specific FAS inhibitor (Kuhajda et al., 2000), when
used at a functional concentration (25 mM) (Figure 6E). In vivo,
FAS activity was significantly increased in epididymal fat of
AIM/ mice compared to that of AIM+/+ mice (Figure 6F). In
addition, supplementation of rAIM via direct injection decreased
FAS activity in epididymal fat of AIM/ mice (Figure 6G).
AIM and FAS Inhibitor C75 Showed Comparable Effects
on Adipocytes
To address whether the effect of AIM on adipocytes resulted
from the suppression of FAS activity, we tested whether treat-
ment of 3T3-L1 adipocytes with AIM or FAS inhibitor C75 had
similar consequences. As expected, rAIM (5 mg/ml) and C75
(25 mM) induced an increase in the efflux of glycerol and FFAs
at comparable levels (Figure 7A). We also assessed the influence
of AIM on adipogenesis, because Schmid et al. (2005) reported
that inhibition of FAS prevented preadipocyte differentiation.
Interestingly, the presence of rAIM during stimulation by insulin,
DEX, and IBMX (48 hr) completely prevented differentiation of
3T3-L1 preadipocytes toward mature adipocytes at a level
equivalent to that observed with C75 (Figure 7B). The numbers
of dead cells did not increase in the presence of rAIM at different
time points, as assessed by staining with trypan blue or propi-
dium iodide (data not shown). This excludes the argument that
rAIM might induce death of 3T3-L1 cells, appearing to decrease
the overall number of mature adipocytes. In addition, AIM did
not simply attenuate either (or all) of the three stimulators viaell Metabolism 11, 479–492, June 9, 2010 ª2010 Elsevier Inc. 483
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Role of AIM in Adipositychemical interaction; coincubation with rAIM followed by
removal of rAIM via column purification did not alter their ability
to induce 3T3-L1 cell differentiation (Figure S7).
Consistent with thesemorphologic results, cells cultured in the
presence of rAIM or C75 showed a marked decrease in mRNA
levels of C/EBPa and PPARg (g1 and g2), the master regulator
genes for adipogenesis (Rosen et al., 1999; Wu et al., 1999a;
Farmer, 2006), as well as of downstream genes characteristic
of functional adipocytes, such as CD36 and GLUT4, compared
to cells differentiated in the absence of rAIM or C75 (Figure 7C).
Altogether, these results indicate that AIM affected adipocytes
by inhibiting FAS activity.
Inhibition of FAS Did Not Activate
cAMP-Dependent Lipolysis
During periods of energy deprivation, adipocytes undergo lipol-
ysis via stimulation of a G protein-coupled receptor/cyclic AMP
(cAMP)-dependent signaling cascade, followed by phosphoryla-
tion of protein kinase A (PKA), which activates hormone-sensi-
tive lipase (HSL). At the same time, the level of adipose triglyc-
eride lipase (ATGL) mRNA also increases (Wu et al., 1999b;
He et al., 2003; Holm, 2003; Finn and Dice, 2006; Zechner
et al., 2005; Duncan et al., 2007; Lafontan, 2008). Interestingly,
however, despite the lipolytic consequences, treatment of 3T3-
L1 adipocytes with rAIM or C75 did not upregulate the phosphor-
ylation of PKA (Figure S8A). In addition, the levels of ATGL and
HSL mRNA did not increase in response to AIM (Figure S8B).
Thus, unlike in a starved situation, inhibition of FAS does not
stimulate cAMP/PKA-dependent lipolysis. Note that the level
of phosphorylation of 50-AMP-activated kinase (AMPK), another
element downstream of cAMP signaling whose activation
inhibits HSL activity, was also not increased by AIM or C75
(Figure S8C).
DISCUSSION
A Role of AIM in Adipocytes
Our present results provide several findings regarding the influ-
ence of AIM on adipocytes. First, AIM is endocytosed into adipo-
cytes via CD36. Second, incorporated AIM binds to cytosolic
FAS protein at various regions responsible for elongation of fatty
acids, release of synthesized palmitate, and stabilization of FASFigure 3. AIM Is Endocytosed via CD36
(A) Differentiated 3T3-L1 adipocytes (ins/DEX/IBMX stimulation +) or undifferentia
ulation ) were incubated with rAIM (5 mg/ml) for 3 hr and stained for AIM (red), PP
PPARg2; bottom panels, AIM + PPARg2 + DAPI (merged), overlaid with phase-c
contained many lipid droplets. Yellow arrows, mature 3T3-L1 adipocytes show
PPARg2; white arrows, cells showing undetectable staining for PPARg2. R
The percentage of cells showing AIM incorporation was calculated for 100 cell
were obtained from three independent experiments.
(B) 3T3-L1 adipocytes treated with rAIM for 3 hr were costained for AIM (red) an
Rab11, respectively); AIM (green) and lysosomes (red: LysoTracker Red DND-99
under a confocal microscope.
(C) Electron microscopic analysis of the same cell samples after immunogold lab
(D) Treatment of 3T3-L1 adipocytes with CD36-neutralizing antibody inhibited e
a-CD36 antibody or control mouse IgA. A total of 100 cells were evaluated for ea
(E) Defective uptake of AIM byCD36/ adipocytes. rAIM (300 mg/mouse in phosp
after injection, mice were sacrificed and sections were prepared from epididym
phages F4/80 (red: middle panels).
Cdimerization. This results in a decrease in FAS enzymatic activity.
Third, the decrease in FAS activity induced by AIM results in
a decrease in lipid droplet storage within adipocytes. Finally,
the size of adipocytes in visceral fat tissue is increased in
AIM/ mice compared to AIM+/+ mice. The physiologic conse-
quence of the lipolytic response induced by AIM remains to be
investigated. It is possible that AIM resists augmentation of
adipose tissue mass, leading to decreased progression of
obesity. Indeed, the increase in weight of visceral fat in mice
fed with a HFD was accelerated in AIM/ mice compared to
AIM+/+ mice (Figure 5B), and it was suppressed by the systemic
administration of rAIM (Figure 5C). Importantly, this antiadiposity
function of AIM appears to be exerted specifically via its effect on
adipocytes, because both AIM/ and AIM+/+ mice showed
comparable metabolic rates (Figure S5). Additional discussion
related to this issue appears in the Supplemental Information
online.
Direct Function of AIM in the Absence of Signaling
Interestingly, exogenous AIM secreted bymacrophages is incor-
porated into adipocytes and directly functions intracellularly.
Such a direct manner of function in the absence of signaling is
unusual in a secreted molecule. However, examples in which
cytosolic delivery of exogenous proteins mediates biological
effects have recently been accumulating. Fibroblast growth
factor (FGF)-1 and -2 (Olsnes et al., 2003; Wesche et al., 2006)
as well as epidermal growth factor (EGF) (Lin et al., 2001) are
transported to the cytosol after internalization via specific recep-
tors, where they trigger cellular events. In addition, many plant
and bacterial toxins, such as ricin and Shiga toxin, are also endo-
cytosed by eukaryotic cells in a receptor-dependent manner and
are translocated into the cytosol to target-specific intracellular
proteins (Sandvig and van Deurs, 2000, 2005). It is also known
that in dendritic cells, some exogenous antigens can access
the cytosol via similar machineries for intracellular transport
and are presented by major histocompatibility complex (MHC)
class I (Ackerman et al., 2005; Giodini and Cresswell, 2008).
Yet it remains unclear how AIM is translocated from endosomal
compartments to the cytosol. Interestingly, incorporated AIM
colocalized with early endosomes but not with late or recycling
endosomes (Figure 3B). This observation implicates the pres-
ence of a specific mechanism to transport AIM from endosomested 3T3-L1 preadipocytes without maturation stimulation (ins/DEX/IBMX stim-
ARg2 (green), and DAPI (blue). Top panels, AIM + DAPI; middle panels, AIM +
ontrast images. In the bottom panels, cells showing strong PPARg2 positivity
ing strong staining for PPARg2; blue arrows, cells showing faint staining for
ight lane (pre): undifferentiated 3T3-L1 preadipocytes without stimulation.
s of each type (graph under photomicrographs; rAIM incorporation). Results
d early, late, or recycling endosomes (green: with antibody to EEA1, Rab7, or
); and AIM (green) and lipid droplets (red: Nile Red). Specimens were observed
eling of AIM. E, endosome; N, nucleus. Scales are indicated by bars.
ndocytosis of rAIM. Incorporation of rAIM was assessed in cells treated with
ch treatment. Results were obtained from three independent experiments.
hate-buffered saline) was i.v. injected intoCD36+/+ andCD36/mice. At 16 hr
al fat tissue. Sections were stained for AIM (green: upper panels) and macro-
ell Metabolism 11, 479–492, June 9, 2010 ª2010 Elsevier Inc. 485
Figure 4. AIM Induces a Lipolytic Response
(A) Differentiated 3T3-L1 adipocytes were challenged with rAIM (5 mg/ml) for 6 days. Cells were stained with Oil Red O before and after rAIM treatment. Repre-
sentative photomicrographs of cells before and after treatment with or without rAIM (5 mg/ml) are presented. Relative droplet size was assessed by evaluating the
diameter of 50 droplets. Error bar indicates SEM. The numbers of droplet-containing cells are also shown (cells/mm2). Data are presented as the means of five
independent areas. Error bar indicates SEM. Before, before rAIM treatment; After, after 6 day rAIM treatment.
(B) Efflux of glycerol and FFAs after culture of 3T3-L1 adipocytes with or without rAIM (5 mg/ml) for 2, 4, or 6 days. Data are shown as culture supernatant concen-
trations. Three independent experiments were performed. Error bar indicates SEM.
(C) Basal levels of glycerol and FFAs in serum from lean (fed with normal chow) and obese (fed with a HFD for 20 weeks) AIM+/+ and AIM/ mice. n = 6 for each
group. Error bar indicates SEM.
(D) 3T3-L1 adipocytes incubated with rAIM (5 mg/ml) for 0, 2, 4, or 6 days were analyzed for mRNA levels of FSP27, Perilipin, Adipophilin, PPARg2, C/EBPa,
GLUT4, and PREF-1 by quantitative PCR. Values were normalized to those of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and presented as relative
expression to that for the 0 day rAIM treatment. Three independent experiments were performed. Error bar indicates SEM.
(E) In vivo experiment. The mRNA levels of the same genes as in (D) were assessed by QPCR with RNA isolated from epididymal fat in AIM/ mice after direct
injection of rAIM (100 mg/whole tissue) or BSA (same amount) into the fat tissues (n = 7 for each). Values were normalized to those of GAPDH and presented as
relative expression to that from fat tissues injected with BSA. Error bar indicates SEM.
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Figure 5. AIM Influences Adipose Tissue Mass
(A) Adipocyte size. In AIM+/+ mice (+/+) and AIM/mice (/) (both fed with a HFD for 20 weeks), epididymal fat sections were stained with H&E, and the diam-
eter of 50 independent adipocytes in different areas was evaluated. Results are presented as averages ± SEM (in pixels). Representative photomicrographs of
adipose tissues are also presented.
(B) Weights for body, visceral fat tissue, and subcutaneous fat tissue from AIM+/+ mice (+/+) and AIM/mice (/) fed with a HFD for 12 weeks. n = 7 for AIM+/+,
and n = 6 for AIM/. Error bar indicates SEM.
(C) AIM/ mice were fed with a HFD for 5 weeks, and during the period, they were i.p. injected with rAIM or BSA twice a week (300 mg/injection/mouse).
The increase in body weight at each week (line graph) and overall body weight and weight of visceral and subcutaneous fat tissues at the end of experiment
(bar graphs) are presented. n = 6 for rAIM-injected mice, and n = 5 for BSA-injected mice. Error bar indicates SEM.
(D) mRNA levels of FSP27, Perilipin and Adipophilin, PPARg2,C/EBPa,GLUT4, and PREF-1were assessed by QPCRwith RNA isolated from epididymal fat from
mice used in (C) at the end of the experiment. Values were normalized to those of GAPDH and presented as relative expression to that of fat tissue injected with
BSA. n = 6 for rAIM-injected mice and n = 5 for BSA-injected mice. Error bar indicates SEM.
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is required, as it has recently been found that the efficient trans-
location of some proteins across the endosomal membrane is
dependent on Hsp90 (Haug et al., 2003; Ratts et al., 2003;CWesche et al., 2006; Giodini and Cresswell, 2008). Additional
experiments are necessary to clarify the mechanism responsible
for AIM translocation from the endosomal compartment to the
cytosol.ell Metabolism 11, 479–492, June 9, 2010 ª2010 Elsevier Inc. 487
Figure 6. AIM Targets FAS
(A) AIM/mice were injected with rAIM (HA tagged) directly into the epididymal fat (total 100 mg at several loci). Three hours after injection, fat tissues were used
to test the association of incorporated rAIM-HA and endogenous cytosolic FAS in fat tissues via coIP using anti-HA antibody. Precipitates were analyzed for the
presence of FAS by western blotting (WB).
(B) Association of rAIM (HA tagged) and FAS (FLAG tagged) in HEK293T cells as determined by coIP assay using anti-Flag or anti-HA antibody.
(C) Left: Each domain of FAS was tagged with the Flag sequence at the N terminus and expressed in HEK293T cells stably expressing AIM-HA, and their asso-
ciation was determined by a coIP assay using anti-Flag or anti-HA antibody. Overexpression of ER or KR domains of FAS resulted in death of a large number of
cells. This caused a decrease in WB signals using these cell lysates (lower panels, lanes ER and KR). Results from IP-FL/WB-FL, IP-HA/WB-HA, and IP-control
IgG (rat or mouse)/WB-FL or -HA are presented in Figure S6. Right: A schematic of head-to-tail dimerized FAS and descriptions of the major function for each
region. Two functional units (distinguished by white and gray) are located on the axis of bound CCs. The AIM-binding domains (DH, CC, ER, and TE) are indicated
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Figure 7. AIM and C75 Exert Comparable Effects on Adipocytes
(A) rAIM (5 mg/ml) or C75 (25 mM)was added to differentiated 3T3-L1 adipocytes for 6 days, and the efflux of glycerol and FFAs was evaluated. Three independent
experiments were performed. Error bar indicates SEM.
(B) Both AIM and C75 inhibited adipogenesis. 3T3-L1 preadipocytes were challenged with rAIM (5 mg/ml) or C75 (25 mM) for 2 days during stimulation of differ-
entiation by insulin, DEX, and IBMX. At day 12 of culture, cells were stained with Oil Red O. In the presence of rAIM or C75, adipocyte differentiation was
completely prevented.
(C) Gene expression profiles at day 12 of culture. Total RNA was isolated from cells, and the mRNA levels for the indicated genes were assessed by QPCR (n = 3
for each group). Values were normalized to those ofGAPDH and presented as relative expression to that of cells cultured in the absence of rAIM or C75. Error bar
indicates SEM.
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in Adipocytes
It is of interest that a functional target of AIM is FAS. Through
association with multiple regions of FAS (Figure 6C), AIM
appears to decrease FAS activity functionally and structurally.
The effect of FAS inhibition on the hypothalamus, which
influences the fat mass in the body, has been studied exten-
sively. Evidence indicates that systemic administration of C75
decreases the production of neuropeptide Y (NP-Y) in the hypo-
thalamus inmice, resulting in amarked loss of appetite and over-
all decreased body weight (Loftus et al., 2000; Makimura et al.,
2001; Kumar et al., 2002; Mobbs and Makimura, 2002; Shimo-
kawa et al., 2002; Kovacs et al., 2004; Liu et al., 2004; Ronnett
et al., 2005; Chakravarthy et al., 2009a). However, AIM/ and
AIM+/+ mice showed comparable levels of food intake (Fig-
ure S5), suggesting that AIM may not have a neurologic effect.
This may be due to the requirement of a specific endocytoticin bold. A monomer FASmolecule is indicated by a shadowed square. KS, ketoac
ER, enoylreductase; KR, ketoreductase; ACP, acyl carrier protein; TE, thioestera
(D) Dimerized FAS is decreased in the presence of AIM. Cell lysates from 3T3-L1
a Tris-acetate gel, and immunoblottingwas carried out to assess dimerized (524 k
from the loading buffer to limit potential degradation of the dimerized form.
(E–G) FAS activity in 3T3-L1 adipocytes treatedwith or without rAIM (5 mg/ml) or C7
and AIM/ epididymal fat tissue challenged with a local intrafat injection of rAIM o
(G). All mice were fed with a HFD for 20 weeks. Samples were lysed and analy
assessed by WB using the same samples (data not shown). n = 6 for each group
Cprocess mediated by CD36, the expression of which is not
reported in hypothalamic cells.
Instead, our present results indicate a direct effect of FAS
inhibition on adipocytes (brought about by either AIM or C75),
which decreases the size and number of lipid droplets, thereby
decreasing adipocyte size. There are several possibilities for the
mechanism of FAS inhibition in the lipolytic response. Because
the inhibition of FAS did not stimulate the cAMP/PKA signaling
cascade (Figure S8), it might activate an unknown cAMP/PKA-
independent lipolytic pathway. Alternatively, because differenti-
ating adipocytes or mice on a HFD undergo progressive lipogen-
esis (increase in lipid droplet storage) and constitutive (basal)
lipolysis at a substantial level (Holm, 2003; Zechner et al.,
2005; Duncan et al., 2007; Lafontan, 2008), the lipolytic outcome
on FAS inhibition might simply represent an acute disturbance of
lipogenesis. Indeed, it is well known that de novo synthesis of
fatty acids via FAS is indispensable for efficient lipogenesisyl synthase; MAT, malonyl/acetyl transferase; DH, dehydrase; CC, central core;
se.
adipocytes maintained with or without rAIM (5 mg/ml) for 2 days were run on
Da) andmonomeric (262 kDa) FAS. Sodium dodecyl sulfate (SDS) was removed
5 (25 mM) for 6 days (E), epididymal fat tissues fromAIM+/+ andAIM/mice (F),
r BSA (total 100 mg for each at several loci within the tissue) 3 hr before analysis
zed for FAS activity. Data are presented for normalized FAS protein levels as
. Error bar indicates SEM.
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in the Supplemental Information online.
Same Mechanism for Different Functions?
Whether other functions of AIM, in particular its antiapoptotic
effect, are carried out by the same molecular mechanism as
that in adipocytes will need to be addressed. As shown in
Figure 2B, macrophages also incorporate exogenous AIM, sug-
gesting that AIM functions in macrophages in amanner similar to
that in adipocytes. Intriguingly, although AIM inhibits apoptosis
in macrophages (Miyazaki et al., 1999; Arai et al., 2005), evi-
dence has shown that suppression of FAS promoted apoptosis
in some cancer cells (Lupu and Menendez, 2006; Menendez
and Lupu, 2007). However, whether apoptosis is inhibited or
accelerated by the suppression of FAS might be dependent on
cell type. Certainly, in some cell types, the overexpression of
FAS accelerated apoptosis, upregulating the expression of proa-
poptotic genes (J.K. and T.M., unpublished data). Alternatively,
intracellular target molecules of AIM may vary in different cell
types and/or in different situations. The mediators for AIM inter-
nalization might also vary, given that thymocytes and NK-T cells,
in which AIM is also effective (Miyazaki et al., 1999; Kuwata et al.,
2003), do not express CD36. This may explain the multiple func-
tions observed for AIM in many cell types.
Perspectives
In conclusion, we have identified a function of AIM, along with its
molecular mechanism, with respect to adipocyte status in fat
tissue. The effects of AIM on other organs important for metab-
olism, such as liver and muscle, remain to be determined.
Further investigation will provide new insights into the role
of AIM in the pathogenesis of obesity as well as metabolic
diseases.
EXPERIMENTAL PROCEDURES
Mice
AIM/mice (Miyazaki et al., 1999) had been backcrossed to C57BL/6 (B6) for
13 generations before being used for experiments. CD36/ mice (Febbraio
et al., 1999) were created and maintained by Febbraio in the Lerner Research
Institute, Cleveland Clinic Foundation. All mice were maintained under a
specific pathogen-free (SPF) condition.
Statistical Analysis
A two-tailed Mann-Whitney test was used to calculate p values. ***p < 0.001,
**p < 0.01, *p < 0.05. Error bars indicate SEM.
Detailed description about reagents for histological analysis, purification of
rAIM, in vitro adipogenesis, FAS constructs, efflux analysis of glycerol and
FFAs, silver-intensified immunogold for electron microscopy, FAS activity
assay, analysis of metabolic rates, quantitative PCR assay, and primers
used for experiments appears in the Supplemental Information online.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Discussion, Supplemental
Experimental Procedures, Supplemental References, and eight figures and
can be found with this article online at doi:10.1016/j.cmet.2010.04.013.
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